Stocks To Buy 2017 — High Risk

: Despite a "chaotic news cycle," markets remained remarkably steady, allowing growth premiums to outperform value premiums significantly.

: Another biotech leader, Nektar returned 387% following positive news regarding its immuno-oncology and painkiller treatments. high risk stocks to buy 2017

: Nine of the top ten performing stocks of the year were in the biotech sector. Companies like Vertex Pharmaceuticals (VRTX) (up 97%) and Dynavax Technologies (DVAX) (up 373%) succeeded based on FDA approvals and breakthrough trial data. : Despite a "chaotic news cycle," markets remained